---
figid: PMC7330112__fonc-10-00894-g0001
figtitle: B-cell receptor (BCR) signaling pathway and BCR inhibitors
organisms:
- NA
pmcid: PMC7330112
filename: fonc-10-00894-g0001.jpg
figlink: pmc/articles/PMC7330112/figure/F1/
number: F1
caption: 'B-cell receptor (BCR) signaling pathway and BCR inhibitors. Following antigen
  binding to the B-cell receptors, BCR signaling is chronically activated in CLL cells.
  As a consequence, the activated BCR pathway results in the production of second
  messengers and the activation of NF-kB and subsequent pro-proliferation and antiapoptotic
  pathways. Targets of the BCR inhibitors: ibrutinib, idelalisib, acalabrutinib, zanubrutinib,
  tirabrutinib, fenebrutinib, vecabrutinib, LOXO-305, ARQ-531, and entospletinib are
  depicted.'
papertitle: Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients
  Treated With Novel Agents.
reftext: Lenka Sedlarikova, et al. Front Oncol. 2020;10:894.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.952533
figid_alias: PMC7330112__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7330112__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7330112__fonc-10-00894-g0001.html
  '@type': Dataset
  description: 'B-cell receptor (BCR) signaling pathway and BCR inhibitors. Following
    antigen binding to the B-cell receptors, BCR signaling is chronically activated
    in CLL cells. As a consequence, the activated BCR pathway results in the production
    of second messengers and the activation of NF-kB and subsequent pro-proliferation
    and antiapoptotic pathways. Targets of the BCR inhibitors: ibrutinib, idelalisib,
    acalabrutinib, zanubrutinib, tirabrutinib, fenebrutinib, vecabrutinib, LOXO-305,
    ARQ-531, and entospletinib are depicted.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD19
  - BCR
  - RN7SL263P
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LYN
  - BTK
  - MTOR
  - SYK
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - PLCG2
  - BLNK
  - PC
  - RPS6KB1
  - BCL2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - EPHB2
  - MAPK1
  - MAPK3
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - ibrutinib
  - acalabrutinib
  - zanubrutinib
  - tirabrutinib
  - fenebrutinib
  - Ag
  - entospletinib
  - Ca2+
---
